| 别名 | APOA1; MGC117399; Apo-AI; ApoA-I; APOAI; Apolipoprotein A1; |
| 基因名称 | Apolipoprotein A1 |
| 蛋白名称 | Apolipoprotein A1 |
| 推荐应用 | |
| 反应物种 | Human Mouse |
| 存储缓冲液 | PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA |
| Human Swissprot No. | P02647 |
| 特异性 | Endogenous |
| 稀释度 | IHC 1:100-1:300 |
| 预测分子量 | 31kDa |
| 运输及保存条件 | -15°C to -25°C/1 year(Do not lower than -25°C) |
| 宿主 | Rabbit |
| 同种型 | IgG,Kappa |
| 背景介绍 | ApoAI (Apolipoprotein A1) is a major component of high density lipoprotein (HDL, the “good cholesterol”) in plasma. It is produced in the liver and small intestine. ApoA1 is a cofactor for lecithin cholesterolacyltransferase (LCAT) that is responsible for the formation of plasma cholesteryl esters and promotes cholesterol efflux from tissues to the liver for excretion. |
| 细胞定位 | Cytoplasm, Secreted |
| 纯化 | Protein A |
| Clonality | Monoclonal |
| 修饰类型 | Unmodified |
| 细胞定位 | Cytoplasm, Secreted |
| 组织表达 | Liver, Small intestine, Plasma, Hepatocellular carcinoma, Intestinal adenocarcinoma, Renal cell carcinoma, Lung adenocarcinoma |
周一至周日 8:00-18:00
